Loading...
Kewaunee Scientific Corp (KEQU) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth, its declining net income, EPS, and gross margin raise concerns about profitability. Additionally, technical indicators and trading signals do not suggest a compelling entry point. The lack of significant trading trends, recent congress trading data, and valuation data further limit confidence in this stock as a strong buy right now.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. However, the RSI is neutral at 48.294, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 41.312, with support at 39.998 and resistance at 42.626.
The acquisition of Nu Aire enhances its product offerings in the laboratory equipment market, which could support future growth.
Net income dropped by 18.72% YoY, EPS fell by 18.81%, and gross margin declined by 3.70% YoY in Q2 FY2026, reflecting profitability challenges. Additionally, no significant trading trends or congress trading data are available to support investor sentiment.
In Q2 FY2026, revenue increased significantly by 46.75% YoY to $70.096M. However, net income dropped by 18.72% YoY to $2.445M, EPS declined by 18.81% to 0.82, and gross margin fell by 3.70% to 28.13%, indicating profitability challenges.
No data available for analyst ratings or price target changes.
